Production (Stage)
Tharimmune, Inc.
THAR
$1.36
-$0.0124-0.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.82% | 11.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.81% | -0.47% | |||
| Operating Income | 33.81% | 0.47% | |||
| Income Before Tax | 33.47% | -0.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.47% | -0.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.47% | -0.65% | |||
| EBIT | 33.81% | 0.47% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 53.83% | 12.78% | |||
| Normalized Basic EPS | 53.83% | 12.77% | |||
| EPS Diluted | 53.83% | 12.78% | |||
| Normalized Diluted EPS | 53.83% | 12.77% | |||
| Average Basic Shares Outstanding | 44.09% | 15.39% | |||
| Average Diluted Shares Outstanding | 44.09% | 15.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||